Strokes attributable to underuse of warfarin and antiplatelets

Journal of Stroke and Cerebrovascular Diseases

Volumn 14, Issue 2, 2005, Pages 55-57

  Olsen, Tom Skyhøj ^a   Rasmussen, Berit Hammershaimb ^a   Kammersgaard, Lars Peter ^a   Germer, Ulla ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Anticoagulation; Inhibitors; Platelets; Prevention; Stroke

Indexed keywords

ANTITHROMBOCYTIC AGENT; WARFARIN;

AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK;

EID: 14744286914     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2004.11.003     Document Type: Article

References (18)

1. R.G. Hart, J.L. Halperin, L.A. Pearce Lessons from the Stroke Prevention in Atrial Fibrillation Trials Ann Intern Med 138 2003 831 838
2. A.S. Go, E.M. Hylek, Y. Chang Anticoagulation therapy for stroke prevention in atrial fibrillation. How well do randomized trials translate into clinical practice? JAMA 290 2003 2685 2692
3. Antiplatelet Trialists' Collaboration Collaborative overview of randomized trials of antiplatelet therapy I. Prevention of death myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients Br Med J 308 1994 81 106
4. H.C. Diener, L. Cunha, C. Forbes European Stroke Prevention Study 2. Dipyridamole and acetylsalisylic acid in the secondary prevention of stroke J Neurol Sci 143 1996 1 13
5. CAPRIE Steering Committee A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events Lancet 348 1996 1329 1339
6. G.W. Albers, N. Bittar, L. Young Clinical characteristics and management of acute stroke patients with atrial fibrillation admitted to U.S. university hospitals Neurology 48 1997 1598 1604
7. T.J. Bungard, W.A. Gahli, K.T. Teo Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 160 2000 41 46
8. M. Man-Song-Hing, A. Laupacis Anticoagulant-related bleeding in older persons with atrialfibrillation Arch Intern Med 163 2003 1580 1586
9. A. Ewans, S. Davis, C. Kilpatrick The morbidity related to atrial fibrillation a tertiary centre in one year 9% of all strokes are potentially preventable J Clin Neurosci 9 2002 286-272
10. A.S. Go, E.M. Hylek, L.H. Borowsky Warfarin use among ambulatory patients with nonvalvular atrial fibrillation. The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study Ann Intern Med 131 1999 927 934
11. R.M. Califf, E.R. DeLong, T. Ostbye Underuse of aspirin in a referral population with documented coronary artery disease Am J Cardiol 89 2002 653 661
12. R.G.J. Gibbs, R. Newson, R. Lawrenson Diagnosis and initial management of stroke and transient ischemic attack across U.K. health regions from 1992 to 1996. Experience of a national primary care database Stroke 32 2001 1085 1090
13. C.H. Rojas-Fernandez, G.C. Kephart, I.S. Sketris Underuse of acetylsalicylic acid in individuals with myocardial infarction, ischemic heart disease or stroke data from the 1995 population-based Nova Scotia Health Survey Can J Cardiol 15 1999 291 296
14. A.G. Rudd, D. Lowe, A. Hoffman Secondary prevention for stroke in the United Kingdom results from the National Sentinel Audit of Stroke Age and Aging 33 2004 280 286
15. H.S. Jœrgensen, A.-M. Plesner, P. Hübbe Marked increase of stroke incidence in men between 1972 and 1990 in Frederiksberg, Denmark Stroke 23 1992 1701 1704
16. B. Johansson, B. Norrving, A. Lindgren Increased stroke incidence in Lund-Orup, Sweden, between 1983 to 1985 and 1993 to 1995 Stroke 31 2000 481 486
17. R. Vibo, J. Korv, S. Haldre First-year results of the third stroke registry in Tartu, Estonia Cerebrovasc Dis 18 2004 227 231
18. Prospective community-based study of stroke in northern Portugal Stroke 35 2004 2048 2053